Traws Pharma's total assets for Q2 2025 were $15.62M, a decrease of -18.05% from the previous quarter. TRAW total liabilities were $7.36M for the fiscal quarter, a -43.66% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.